| （単位：千ドル） | 3Q20 | 1Q21 | 2Q21 | 3Q21 | 1Q22 | 2Q22 | 3Q22 | 1Q23 | 2Q23 | 3Q23 | 1Q24 | 2Q24 | 3Q24 | 1Q25 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 研究開発費 | - | - | - | - | 3,680 | 975 | 381 | 525 | 909 | 1,651 | 717 | 1,394 | 830 | 858 |
| 営業費用 | 0 | 468 | 842 | 844 | 6,586 | 1,860 | 1,199 | 1,619 | 1,933 | 2,777 | 1,902 | 2,522 | 1,796 | 2,094 |
| 営業利益 | - | - | - | - | -6,587 | -1,861 | -1,200 | -1,620 | -1,934 | -2,778 | -1,903 | -2,523 | -1,797 | -2,095 |
| 純利益 | -1 | 1,178 | -1,332 | -758 | -6,617 | -1,835 | -1,171 | 6,159 | -1,449 | -2,629 | -2,682 | -8,390 | -2,242 | -2,052 |
| 一株あたり利益 | - | - | - | - | - | -0.12 | -0.06 | 2.79 | -0.25 | -0.42 | -2.46 | -5.13 | -0.84 | -2.11 |
| 希薄化後一株あたり利益 | - | - | - | - | - | -0.12 | -0.06 | 1.96 | -0.25 | -0.42 | -2.46 | -5.13 | -0.84 | -2.11 |